Contraceptive Technology Update – November 1, 2006
November 1, 2006
View Issues
-
New methods gain favor with women, but Pill use remains strong
The contraceptive vaginal ring (NuvaRing, Organon; West Orange, NJ) and the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical; Raritan, NJ) have become standard options at many facilities since both were approved by the Food and Drug Administration (FDA) in 2001. -
Which OCs do you choose? Readers exchange views
When it comes to prescribing an oral contraceptive (OC) for your patient, which one do you select? Participants in the 2006 Contraception Survey conducted by Contraceptive Technology Update say their No. 1 oral contraceptive (OC) of choice for a 21-year-old nonsmoker is Yasmin, a monophasic pill containing 3 mg drospirenone and 0.030 mg ethinyl estradiol from Berlex, Wayne, NJ. -
Readers share strategies on OC use
Your next patient is a newly divorced 41-year-old woman who wants to use an oral contraceptive (OC). When you check her chart, you note that she smokes 10 cigarettes a day. What is your next move? -
Intrauterine method making inroads in use
Intrauterine contraception is highly convenient. It provides long-term protection against pregnancy, and the method is promptly reversible. Where does it fit in your facility's cafeteria of options? -
EC: Family planners weigh in on method use
Will you change your prescribing practice with the Food and Drug Administration's (FDA) recent approval of over the counter (OTC) status for the emergency contraceptive Plan B? -
Washington Watch: Unintended Pregnancy Reduction Act introduced
In May 2006, Hillary Clinton (D-NY) and Harry Reid (D-NV) two senators with vastly different positions on abortion stood together to introduce landmark legislation promising to significantly reduce the number of abortions in this country.